NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 20 04:00PM ET
0.4288
Dollar change
-0.0025
Percentage change
-0.58
%
IndexRUT P/E- EPS (ttm)-2.47 Insider Own34.73% Shs Outstand53.38M Perf Week-10.85%
Market Cap22.92M Forward P/E- EPS next Y-1.27 Insider Trans0.06% Shs Float34.88M Perf Month-24.27%
Income-130.02M PEG- EPS next Q-0.42 Inst Own48.49% Short Float17.34% Perf Quarter-63.97%
Sales0.00M P/S- EPS this Y35.35% Inst Trans2.39% Short Ratio7.69 Perf Half Y-67.76%
Book/sh1.65 P/B0.26 EPS next Y24.08% ROA-77.96% Short Interest6.05M Perf Year-97.08%
Cash/sh1.83 P/C0.23 EPS next 5Y28.16% ROE-102.99% 52W Range0.41 - 15.35 Perf YTD-74.32%
Dividend Est.- P/FCF- EPS past 5Y-32.29% ROI-128.50% 52W High-97.21% Beta1.10
Dividend TTM- Quick Ratio5.47 Sales past 5Y-35.07% Gross Margin- 52W Low4.59% ATR (14)0.05
Dividend Ex-Date- Current Ratio5.47 EPS Y/Y TTM33.43% Oper. Margin- RSI (14)35.76 Volatility11.45% 10.76%
Employees80 Debt/Eq0.19 Sales Y/Y TTM- Profit Margin- Recom1.33 Target Price2.30
Option/ShortYes / Yes LT Debt/Eq0.15 EPS Q/Q18.81% Payout- Rel Volume0.56 Prev Close0.43
Sales Surprise- EPS Surprise-25.05% Sales Q/Q- EarningsMay 08 BMO Avg Volume786.35K Price0.43
SMA20-13.21% SMA50-27.10% SMA200-69.68% Trades Volume443,205 Change-0.58%
Date Action Analyst Rating Change Price Target Change
Mar-06-25Upgrade Jefferies Hold → Buy $2 → $3
Dec-19-24Downgrade Jefferies Buy → Hold $12 → $2
Mar-08-24Downgrade Stifel Buy → Hold $10 → $14
Dec-08-23Upgrade Jefferies Hold → Buy $8 → $18
Dec-22-21Downgrade Jefferies Buy → Hold $65 → $25
Sep-30-21Initiated Stifel Buy $106
May-05-21Resumed Credit Suisse Outperform $98
Apr-26-21Resumed Credit Suisse Outperform $98
Apr-06-21Initiated UBS Buy
Feb-10-21Initiated H.C. Wainwright Buy $100
Today 08:00AM
May-13-25 08:00AM
May-08-25 08:30AM
May-02-25 08:00AM
Apr-28-25 07:51AM
01:10PM Loading…
Apr-25-25 01:10PM
09:00AM
Apr-07-25 08:00AM
Mar-20-25 09:55AM
Mar-08-25 07:33AM
Mar-07-25 01:27PM
Mar-06-25 04:01PM
Mar-05-25 08:00AM
Feb-27-25 08:00AM
Feb-18-25 08:00AM
02:44PM Loading…
Jan-23-25 02:44PM
08:00AM
Jan-22-25 04:01PM
09:00AM
08:00AM
Jan-21-25 05:00PM
Jan-07-25 09:40AM
08:00AM
Dec-19-24 08:57AM
Dec-18-24 08:00AM
Dec-12-24 08:00AM
Dec-10-24 09:00AM
Nov-26-24 08:00AM
Nov-21-24 09:35AM
Nov-14-24 08:00AM
04:00PM Loading…
Nov-07-24 04:00PM
Nov-04-24 08:00AM
Nov-01-24 05:30PM
Oct-10-24 07:04PM
Sep-09-24 08:00AM
Sep-04-24 08:00AM
Aug-08-24 04:05PM
Aug-06-24 04:01PM
Aug-01-24 09:05AM
06:52AM
Jul-31-24 04:01PM
05:30AM
Jun-17-24 11:00AM
Jun-03-24 09:35AM
Jun-02-24 10:00AM
May-29-24 09:00AM
May-16-24 02:54AM
May-14-24 09:55AM
May-10-24 02:21PM
May-09-24 10:57PM
04:00PM
May-08-24 05:38PM
May-07-24 09:00AM
Apr-30-24 09:00AM
Apr-24-24 10:00AM
Apr-11-24 09:30AM
Apr-09-24 05:30PM
Apr-06-24 01:33AM
Mar-08-24 03:48PM
Mar-07-24 10:53PM
10:41PM
04:03PM
Mar-05-24 04:30PM
Jan-03-24 08:00AM
Dec-22-23 04:21PM
Nov-13-23 04:47PM
04:05PM
Nov-01-23 04:05PM
Oct-10-23 04:05PM
Oct-06-23 04:59AM
Oct-05-23 10:58AM
08:00AM
Oct-04-23 04:10PM
11:39AM
Oct-03-23 11:15AM
09:36AM
06:00AM
Oct-02-23 04:05PM
Sep-06-23 08:00AM
Aug-31-23 07:00AM
Aug-14-23 07:31PM
Aug-10-23 04:01PM
09:55AM
Jun-26-23 07:00AM
May-11-23 04:01PM
May-09-23 07:00AM
Apr-25-23 07:00AM
Apr-19-23 11:36AM
Mar-14-23 08:00AM
Mar-13-23 07:00AM
Mar-09-23 04:01PM
Feb-16-23 07:00AM
Jan-05-23 07:00AM
Jan-03-23 07:00AM
Dec-12-22 10:00AM
Nov-29-22 07:00AM
Nov-08-22 04:01PM
Nov-03-22 09:00AM
Nov-02-22 07:00AM
Oct-31-22 07:00AM
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pinto ShellySVP, FINANCE AND CAOFeb 19 '25Sale1.1555063387,352Feb 21 04:25 PM
Pons JaumePRESIDENT & CSOFeb 19 '25Sale1.151,3261,525579,388Feb 21 04:23 PM
Lettmann JasonCHIEF EXECUTIVE OFFICERFeb 19 '25Sale1.152,1592,483170,270Feb 21 04:20 PM
Pinto ShellyInterim CFOJan 06 '25Sale1.802,2213,99887,902Jan 08 04:10 PM
Pinto ShellyInterim CFODec 30 '24Sale1.581,4262,25390,123Jan 02 04:46 PM
Pons JaumePRESIDENT & CSODec 30 '24Sale1.5810,79617,060580,714Jan 02 04:43 PM
Hemrajani RekhaDirectorDec 02 '24Buy1.5530,00046,40433,000Dec 04 04:17 PM
Pinto ShellySVP, FINANCE AND CAOAug 14 '24Sale2.585641,45591,549Aug 16 05:10 PM
Randolph SophiaCHIEF MEDICAL OFFICERAug 14 '24Sale2.581,3653,522325,711Aug 16 05:09 PM
Pons JaumePRESIDENT & CSOAug 14 '24Sale2.581,9374,997591,510Aug 16 05:06 PM
Pons JaumePRESIDENT & CSOJul 11 '24Option Exercise0.9920,00019,800613,447Jul 15 04:06 PM
Pons JaumePRESIDENT & CSOJul 11 '24Sale7.9020,000158,076593,447Jul 15 04:06 PM
Pinto ShellySVP, FINANCE AND CAOJul 05 '24Sale5.501,82310,02592,113Jul 09 04:09 PM
Pinto ShellySVP, FINANCE AND CAOJul 01 '24Sale5.821,3737,98993,936Jul 03 05:03 PM
Randolph SophiaCHIEF MEDICAL OFFICERJul 01 '24Sale5.823,27319,045327,076Jul 03 05:02 PM
Pons JaumePRESIDENT & CSOJul 01 '24Sale5.8210,75862,599593,447Jul 03 05:00 PM
GARCIA PETER SCHIEF FINANCIAL OFFICERJun 13 '24Buy8.5312,000102,338122,348Jun 17 07:29 AM
Pons JaumePRESIDENT & CSOJun 04 '24Option Exercise0.9920,00019,800624,205Jun 06 04:06 PM
Pons JaumePRESIDENT & CSOJun 04 '24Sale8.4320,000168,652604,205Jun 06 04:06 PM